NasdaqCM - Nasdaq Real Time Price USD

Cosmos Health Inc. (COSM)

0.4200
-0.0108
(-2.51%)
At close: May 9 at 4:00:00 PM EDT
0.4198
-0.00
(-0.05%)
Pre-Market: 8:03:42 AM EDT
Loading Chart for COSM
  • Previous Close 0.4308
  • Open 0.4240
  • Bid 0.3010 x 200
  • Ask 0.5374 x 200
  • Day's Range 0.4100 - 0.4352
  • 52 Week Range 0.2800 - 1.5800
  • Volume 253,436
  • Avg. Volume 404,933
  • Market Cap (intraday) 11.46M
  • Beta (5Y Monthly) 4.30
  • PE Ratio (TTM) --
  • EPS (TTM) -1.1700
  • Earnings Date Apr 16, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus. The company offers medicines, OTC medicines, nutraceutical products, vitamins, minerals, and dietary health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names. Other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag to promote peaceful sleep; Otikon ear drops, which is a Class II medical device in the form of ear drops; and Bio-bebe, an organic infant care and nutrition brand. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies, and independent specialty distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

www.cosmosholdingsinc.com

149

Full Time Employees

December 31

Fiscal Year Ends

Recent News: COSM

View More

Performance Overview: COSM

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

COSM
37.22%
S&P 500 (^GSPC)
3.77%

1-Year Return

COSM
38.24%
S&P 500 (^GSPC)
8.55%

3-Year Return

COSM
50.00%
S&P 500 (^GSPC)
41.81%

5-Year Return

COSM
82.28%
S&P 500 (^GSPC)
93.18%

Compare To: COSM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: COSM

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    11.46M

  • Enterprise Value

    22.94M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.15

  • Price/Book (mrq)

    0.47

  • Enterprise Value/Revenue

    0.42

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -29.73%

  • Return on Assets (ttm)

    -15.85%

  • Return on Equity (ttm)

    -53.43%

  • Revenue (ttm)

    54.43M

  • Net Income Avi to Common (ttm)

    -22.38M

  • Diluted EPS (ttm)

    -1.1700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    336.25k

  • Total Debt/Equity (mrq)

    48.18%

  • Levered Free Cash Flow (ttm)

    -649.54k

Research Analysis: COSM

View More

Company Insights: COSM

Research Reports: COSM

View More

People Also Watch